Search all trials

Find therapies in clinical trials near you – page 13

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Prophylaxis of nausea and vomiting

Not recruiting

Registered drug

Study on Aprepitant for Preventing Nausea and Vomiting After Bariatric Surgery in Patients

Registered drug

Estonia

Participants:18–64 years · 65+ years
Substances:Aprepitant

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

InvestigationalNo placebo

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Estonia

Participants:18–64 years · 65+ years
Substances:Bi 1015550

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Investigational

Study on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Investigational

Estonia

Participants:18–64 years · 65+ years
Substances:Itepekimab

Contact Research Centre

Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn's Disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn's Disease

Investigational

Estonia

Participants:18–64 years
Substances:Golimumab

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Estonia

Participants:18–64 years
Substances:Golimumab

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Registered drug

Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Previously Used Anti-TNF Therapy

Registered drug

Estonia

Participants:18–64 years · 65+ years
Substances:Tildrakizumab

Contact Research Centre

Adenocarcinoma gastric+1

Not recruiting

Registered drug

Study of Pembrolizumab with Chemotherapy for Patients with Gastric or Gastroesophageal Junction Cancer

Registered drug

Estonia

Participants:18–64 years
Substances:Calcium Folinate

Contact Research Centre

Paroxysmal nocturnal haemoglobinuria

Not recruiting

Registered drugNo placebo

Study Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors

Registered drugNo placebo

Estonia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Crovalimab

Contact Research Centre

Primary biliary cholangitis

Not recruiting

Registered drug

Study on the Effects of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis Who Cannot Tolerate Ursodeoxycholic Acid

Registered drug

Estonia

Participants:18–64 years · 65+ years
Substances:Bezafibrate

Contact Research Centre

Crohn's disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease

Investigational

Estonia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy

Registered drug

Estonia

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Relapsing multiple sclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Registered drug

Estonia

Participants:18–64 years
Substances:Charcoal, Activated

Contact Research Centre

Find therapies in clinical trials near you – page 13

192 trials match your criteria

Prophylaxis of nausea and vomiting

Study on Aprepitant for Preventing Nausea and Vomiting After Bariatric Surgery in Patients

Idiopathic pulmonary fibrosis

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

Chronic obstructive pulmonary disease

Study on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn's Disease

Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn's Disease

Colitis ulcerative

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Psoriatic arthropathy

Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Previously Used Anti-TNF Therapy

Adenocarcinoma gastric+1

Study of Pembrolizumab with Chemotherapy for Patients with Gastric or Gastroesophageal Junction Cancer

Paroxysmal nocturnal haemoglobinuria

Study Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors

Primary biliary cholangitis

Study on the Effects of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis Who Cannot Tolerate Ursodeoxycholic Acid

Crohn's disease

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease

Non-small cell lung cancer

Study of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy

Relapsing multiple sclerosis

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.